Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease.
about
Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease.SIRT1 inhibition causes oxidative stress and inflammation in patients with coronary artery disease.A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in humanPiceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line.SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases.Reduced SIRT1 expression correlates with enhanced oxidative stress in compensated and decompensated heart failure.Protective effects of sirtuins in cardiovascular diseases: from bench to bedsideSirt1 expression is associated with CD31 expression in blood cells from patients with chronic obstructive pulmonary disease.Over-expression of heat shock protein 70 protects mice against lung ischemia/reperfusion injury through SIRT1/AMPK/eNOS pathway.The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis.Sirt1: Role Under the Condition of Ischemia/Hypoxia.BDNFVal66met polymorphism: a potential bridge between depression and thrombosis.Silent information regulator 1 (SIRT1) promotes the migration and proliferation of endothelial progenitor cells through the PI3K/Akt/eNOS signaling pathway.Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.In Patients with Coronary Artery Disease and Type 2 Diabetes, SIRT1 Expression in Circulating Mononuclear Cells Is Associated with Levels of Inflammatory Cytokines but Not with Coronary Lesions.
P2860
Q30381121-61F10398-E1F6-4449-B34D-EAA982057555Q33784311-B7B5FD66-F6B6-4DC3-8A56-258B8BE48281Q34467732-BAF4C688-6FA8-4AC6-B55F-2307CFEA5952Q34577984-AE20EAB5-6FE0-42B0-A44A-43117418ACE8Q35109034-9FFA18AE-B631-4FE5-BE0C-2608D0CFD9DCQ35947151-0E51581A-B414-4E5E-93F8-61C54AD71DEBQ36387714-F5B07DE8-1523-41FE-82F3-83BCE5C2BA79Q37370002-804265B4-FCA3-4F98-ABB4-5839DCB9E210Q37393476-EE0D7025-E414-4778-8FDC-D7D8C07BA107Q37423513-B651769C-ACDB-485A-85A9-239EC2D3AE98Q38772159-512CFBAA-6BE1-464A-BA0C-2AA724ED791DQ40170492-F5AF27FE-5117-4E63-809F-54C1DDCA6B00Q40926121-35378EC8-382D-4656-8611-FBB31B927261Q41591129-1AD33E62-ACFF-45FD-92D5-D8D14F014E57Q41887148-1A8D23C9-86A0-4799-A83A-3C03F95439BF
P2860
Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@ast
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@en
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@nl
type
label
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@ast
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@en
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@nl
prefLabel
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@ast
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@en
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@nl
P2093
P2860
P50
P1433
P1476
Peripheral blood monocyte Sirt ...... with coronary artery disease.
@en
P2093
Alexander Akhmedov
Alexander Breitenstein
Christophe A Wyss
Danielle Hof
Fabian C Franzeck
Matthias Hasun
Meliana Riwanto
Remo D Spescha
Willibald Maier
P2860
P304
P356
10.1371/JOURNAL.PONE.0053106
P407
P577
2013-01-29T00:00:00Z